The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists. 1996

E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
Department of Pharmacology, The University of Arizona, College of Medicine, Tucson 85724, USA.

In the present study, we replaced the third extracellular loop of the human delta-opioid receptor with that of the human mu-opioid receptor. A modified polymerase chain reaction overlap extension method was used to achieve the exact splicing in the chimera to show the importance of the extracellular loop in ligand binding without interference from transmembrane substitutions. The replacement of the third extracellular loop did not alter the affinity of [3H]diprenorphine but caused a dramatic decrease in the affinity of both the delta-selective peptide agonists cyclo[D-Pen2,4'Cl-Phe4,D-Pen5]enkephalin and deltorphin II and the delta-selective nonpeptide agonists SNC 121 and (-)TAN 67. The affinities of the mu-selective peptide agonist [D-Ala2-MePhe4-Gly-ol5]enkephalin and the mu-preferring nonpeptide agonist morphine were not affected. Site-directed mutagenesis studies show that the mechanism of ligand recognition might be different for each structural class of opioid ligands.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011804 Quinolines
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D017465 Receptors, Opioid, delta A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins. Opioid Receptors, delta,Receptors, delta,Receptors, delta Opioid,delta Receptors,delta Opioid Receptor,delta Receptor,Opioid Receptor, delta,Receptor, delta,Receptor, delta Opioid,delta Opioid Receptors

Related Publications

E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
June 1995, The Journal of biological chemistry,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
September 2000, European journal of pharmacology,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
May 2004, The Journal of biological chemistry,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
May 1997, European journal of pharmacology,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
September 2002, European journal of pharmacology,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
May 2000, European journal of pharmacology,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
September 1994, European journal of pharmacology,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
September 2000, FEBS letters,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
June 2006, Molecular interventions,
E V Varga, and X Li, and D Stropova, and T Zalewska, and R S Landsman, and R J Knapp, and E Malatynska, and K Kawai, and A Mizusura, and H Nagase, and S N Calderon, and K Rice, and V J Hruby, and W R Roeske, and H I Yamamura
January 1985, Psychopharmacology bulletin,
Copied contents to your clipboard!